MTOR and cancer: The combination treatment of AEE788 and temsirolimus could inhibit phosphorylation of mTOR, thereby restraining the proliferation of BRCA cells.[44] Docetaxel could disrupt the microtubule meshwork, thereby destroying the cancer cells.